SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Granules India informs about outcome of board meeting

15 May 2024 Evaluate
Granules India has informed that the Board of Directors at their meeting dated 15th May 2024 has approved the audited financial results (Standalone & Consolidated) for the fourth quarter and financial year ended on March 31, 2024 prepared under Indian Accounting Standards (Ind - AS) along with the Auditor’s report thereon. Recommended to the members, a final dividend of Rs. 1.50/- per share of the face value of Re. 1/- each for the financial year 2023-24 representing 150% of the paid-up equity share capital of the Company. The record date for payment of the final dividend shall be July 30, 2024. Re-appointed Harsha Chigurupati (DIN:01606477) as a Whole-time Director of the Company for a further term of 5(Five) years since his current term is concluding on August 28, 2024. His re-appointment is subject to the approval of the members. Re-appointed Dr. Krishna Prasad Chigurupati (DIN: 00020180) as a Chairman & Managing Director of the Company for a further term of 5(Five) years since his current term is concluding on August 31, 2024. His re-appointment is subject to the approval of the members. Fixed the date of the 33rd Annual General Meeting of the members of the Company on Tuesday, August 06, 2024. Fixed the date of Book closure from July 31, 2024 to August 06, 2024 for the purpose of the 33rd Annual General Meeting of the Company. The meeting of the Board of Directors of the Company commenced at 09.00 AM and concluded at 12.10 PM.

The above information is a part of company’s filings submitted to BSE.

Granules India Share Price

654.40 3.60 (0.55%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×